Literature DB >> 2763501

A novel method for removal of human immunodeficiency virus: filtration with porous polymeric membranes.

Y Hamamoto1, S Harada, S Kobayashi, K Yamaguchi, H Iijima, S Manabe, T Tsurumi, H Aizawa, N Yamamoto.   

Abstract

We propose a new method to rid solutions of a virus by using a novel regenerated multilayered structured cellulose membrane (BMM). When the filtrate of human immunodeficiency virus (HIV) preparation was obtained through BMM it showed no infectivity. Electron microscopic observation revealed that HIV was completely caught by the multilayers of the BMM. Conveniently, BMM was seldomly found to adsorb protein molecules and also to have a high filtration rate. These characteristics may have a use in the removal of other variously sized pathogenic agents from plasma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2763501     DOI: 10.1111/j.1423-0410.1989.tb02034.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  6 in total

Review 1.  Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.

Authors:  C Harbour; G Woodhouse
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

Review 2.  Safety of blood transfusion: the Japanese experience.

Authors:  H Ikeda
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

3.  Concentration of live retrovirus with a regenerated cellulose hollow fiber, BMM.

Authors:  M Makino; G Ishikawa; K Yamaguchi; Y Okada; K Watanabe; Y Sasaki-Iwaki; S Manabe; M Honda; K Komuro
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.

Authors:  Daniel Suez; Mark Stein; Sudhir Gupta; Iftikhar Hussain; Isaac Melamed; Kenneth Paris; Amy Darter; Christelle Bourgeois; Sandor Fritsch; Heinz Leibl; Barbara McCoy; David Gelmont; Leman Yel
Journal:  J Clin Immunol       Date:  2016-08-31       Impact factor: 8.317

5.  Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles.

Authors:  Jun Adan-Kubo; Muneo Tsujikawa; Kadue Takahashi; Tomoko Hongo-Hirasaki; Kaoru Sakai
Journal:  Biotechnol Prog       Date:  2019-07-03

6.  Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies.

Authors:  M Borte; G Kriván; B Derfalvi; L Maródi; T Harrer; S Jolles; C Bourgeois; W Engl; H Leibl; B McCoy; D Gelmont; L Yel
Journal:  Clin Exp Immunol       Date:  2016-10-18       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.